Notice Number: NOT-DK-16-006

Key Dates
Release Date: January 20, 2016

Related Announcements
NOT-DK-24-011 - Notice of Update to National Institute of Diabetes and Digestive and Kidney Disease Central Repository (NIDDK-CR) Cost Recovery Policy.
PAR-14-301
PAR-13-228
RFA-DK-15-018

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice informs the research community that the NIDDK Repositories (www.niddkrepository.org) will begin recovering costs associated with providing samples to approved requestors.

In Section 218 of the 2016 Omnibus Appropriations bill, Congress gave NIH explicit authority to retain proceeds from sales of research substances.

As of January 20, 2016, all new requests will have to pay for the cost of retrieving, aliquoting and shipping biosamples and/or genetic samples. A price list is posted at https://www.niddkrepository.org/pages/costs/.

When a new request is submitted, the Repository will provide a cost estimate for fulfillment. Once a request is approved, the requester will need to agree in writing to pay the fees. For requests that cost more than $5000, payment is required before the shipment is processed. All international requesters will need to provide payment before the shipment is processed, regardless of amount.

This policy applies to new requests. It will also be applied to existing ancillary studies when the ancillary study submits a request for additional samples beyond those originally approved. It does not apply to requests by studies for their own samples for internal use, as specified in the study’s protocol, or to existing approved requests by ancillary studies or external investigators. Moreover, it will not apply to any applicant for NIDDK Funding Opportunity Announcements PAR-14-301, NIDDK Central Repositories Non-renewable Sample Access (X01); PAR-13-228, Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01); or RFA-DK-15-018, Understanding the Pathogenesis and Etiology of Type 1 Diabetes Using Biosamples and Subjects from Clinical Studies (DP3) whose grant application was submitted before January 20, 2016.

All other aspects of these Funding Opportunity Announcements remain the same.

Inquiries

Please direct all inquiries to:

Rebekah Rasooly, Ph. D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-6007
Email: [email protected]